PANews reported on October 26th that biodefense startup Valthos secured $30 million in funding from OpenAI Startup Fund, Lux Capital, and Founders Fund, according to Decrypt. The company's AI system can update medical responses based on the speed of biological threats, enabling researchers and government agencies to identify and respond to pathogens as quickly as possible.
Valthos was founded in New York last November by Kathleen McMahon, former head of life sciences at Palantir Technologies; Tess van Stekelenburg, a former computational neuroscience researcher at the University of Oxford; and founding artificial intelligence engineer Victor Mao, formerly a research engineer at Google DeepMind.
